@TERMISBPC

The only Global start-up accelerator programme specific to tissue engineering and regenerative medicine fields. Click to subscribe: https://xitter.cf/t.co/lx8IUre41B

 Krakow, Poland
termisbpc.org
Joined December 2015
  • Tweets590
  • Following185
  • Followers523
106Media
TERMIS BPC #TERMIS2022 retweeted
TERMIS SYIS EU@SyisEu28 Apr 2022
Are you attending @TermisEU2022? 🎊 Here is a list for you to check: 1. Tickets ready?✈️ 2. Accomodation booked? 🏨 So you just need to vote for 2 panels happening with @SyisEu from the poll below👇
19%Social media 4scientists
35%Career panel
23%Green lab
23%Publish/Grant writing
31 votes • Final results
6
4
11
TERMIS BPC #TERMIS2022 retweeted
TERMIS-EU 2022 Krakow@TermisEU202229 Apr 2022
Well well ... basically 2⃣ months to go! #TERMISEU2022 🇵🇱 A stunning city 🏰🐉 and an amazing scientific community👩‍🔬 are waiting for you!
1
6
27
TERMIS BPC #TERMIS2022 retweeted
TERMIS-EU 2022 Krakow@TermisEU20227 Dec 2021
Good news! 💊 D e a d l i n e E x t e n d e d 🧫 to December 15th, 2021📆 Submit your Symposium Proposal, we look forward to receiving amazing proposals and get inspired by innovative thinking! #term #tissueengineering #regenerativemedicine
TERMIS-EU 2022 Krakow@TermisEU202217 Nov 2021
You are still on time to submit your Symposium Proposal for TERMIS-EU 2022 🇵🇱 Don’t miss your chance🚀 ⏰ Deadline is November 22nd, 2021 For more info, visit our website! 👉 eu2022.termis.org/
8
9
TERMIS BPC #TERMIS2022 retweeted
TERMIS SYIS EU@SyisEu16 Nov 2021
Starting in 10 minutes!
TERMIS SYIS EU@SyisEu11 Nov 2021
Replying to @SyisEu
Tue 16th (8.30-10 CET) we have 👉@GabrielLiguori (linkedin.com/company/tissuel…) 👉@MTryfonidou (rmutrecht.org/marianna-tryfo…) 👉@drmgmonaghan (tcd.ie/mecheng/staff/monaghm…) 👉 Mikhail Tsurkan (TissueGUARD tissueguard.de/) chaired by our own @AriFerrini + Lizette Utomo
2
7
Need some advice writing your startup's business plan? We have a series of 5 pre-recorded webinars available on-demand to help you get your TERM assets through to market. Get first-hand advice from a series of industry leaders at the link. termisbpc.org/pap/
1
1
Only just over a month left to apply for the 2019 TERMIS-EU BPC! Get your business plans ready and submit now for a chance to present your startup at the @EuTermis 2019 European Congress. Apply here -> termisbpc.org/
2
3
The 2019 TERMIS Business Plan Competition @TERMISBPC is open for applications!! If your tissue engineering/regen med startup needs mentorship & a cash boost, visit termisbpc.org and hit 'Apply' for a chance to pitch at TERMIS-EU 2019.
1
2
Take your startup success to the next step after @TERMISBPC - applications for @RebelBio Accelerator are open until 1st July - an opportunity win £200K on a three month incubator programme. #startup #lifescience
3
5
lnkd.in/eGWDw9Z lnkd.in/e5i_Qn9
1
TERMIS BPC #TERMIS2022 retweeted
Sven Kili@Biosurgerysven2 Jun 2018
Avro bio files for $86m IPO and set to become a major player in the ultra rare gene therapy space. fiercebiotech.com/biotech/lo…

Looking to unseat Sanofi and Shire drugs, Atlas gene therapy startup Avrobio files for $86M IPO

Avrobio has filed for an $86.25 million IPO. | Avrobio has filed for an $86.25 million IPO. The offering would give the Atlas Venture-backed startup the means to run clinical trials of gene therapies...

fiercebiotech.com
3
6
All star meeting @Stanford with a community of #celltherapy centres represented ft. David DiGiusto, Adrian Gee, Bruce Levine @StanfordMed @CAGTHouston @BLLPHD @PennMedicine @Baylor @ISCTglobal @TERMISBPC – at Stanford, CA
5
8
TERMIS BPC #TERMIS2022 retweeted
FierceBiotech
@FierceBiotech6 Mar 2018
Autolus, Arix and Syncona all emphasized that the IPO plan is in the preliminary stages and that the timing and terms are yet to be nailed down. The IPO could even fall through altogether: ow.ly/M1Qr30iMAlr

Next-gen CAR-T biotech Autolus files for IPO

Autolus files | Autolus files for a Nasdaq IPO after kicking off three phase 1/2 trials of its CAR-Ts and bringing its private financing haul up to $173 million.

fiercebiotech.com
6
5
lnkd.in/gF2tw-R lnkd.in/gZnDdtj
A memorandum of understanding between @CGTCatapult and the Japanese Society for Regenerative Medicine was signed today. Pictured are Dr John Brown, CGTCatapult Chairman, and Yoshiki Sawa, President @JSRM_Official #Collaboration #RegenerativeMedicine - ow.ly/rLKR30iDXpa
13
13
TERMIS BPC #TERMIS2022 retweeted
Innovate UK
@innovateuk19 Feb 2018
#Autolus develops cancer therapies which will hopefully #transform lives with new therapies such as T-cell therapies #Innovateblog @innovateuk @UKRI_News ow.ly/OKPy30iucqE
4
1
1
Secondments can provide invaluable opportunity to broaden your skills, think laterally and change your perspective. @MeDe_Innovation @ISCTglobal @SyisEu #phdchat #ecrchat xitter.cf/dr_d_miles/status/9637… – at Boston, MA
Danielle Miles@Dr_D_Miles14 Feb 2018
The value of a secondment to a Medtech Researcher linkedin.com/pulse/inspiring… #secondment #researcher #leedscityregion @TranslateMedTec
5
Case study: How @CGTCatapult worked with #cryochain technology experts @Asymptote_Ltd to create a new product and solve barriers in thawing #supplychain #coldchain - ow.ly/CMjO30imPrU
2
3
TERMIS BPC #TERMIS2022 retweeted
MIT Technology Review
@techreview12 Feb 2018
The cost of gene therapy is trending steadily downward, which is theoretically great for patients, but it still remains to be seen whether insurance will cover them. trib.al/csdXS5x

Tracking the Cost of Gene Therapy

Though expensive now, prices could get cheaper for more common diseases.

technologyreview.com
1
23
40
TERMIS BPC #TERMIS2022 retweeted
Simon ellison@Simon_H_Ellison11 Feb 2018
Fujifilm and Takeda Announce Collaboration to Develop Regenerative Medicine Therapies using Cardiomyocytes Derived from iPSC lnkd.in/ggqusPS
1
2
@RegMedNet @CCRM_au @MeDe_Innovation please retweet, we would really appreciate your support!
1
1
Load more